Results 111 to 120 of about 2,235,257 (308)

The future of the Dutch egg processing industry [PDF]

open access: yes
This research examines the competitiveness of the Dutch egg products industry, as well as the consequences of tightening up the laws concerning layer poultry on the competitive position of the Dutch egg production industry.
Cotteleer, Geerte   +2 more
core   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Control tools to detect processed animal proteins in feed and in animal by-products: specificity and challenges [PDF]

open access: yesBiotechnologie, Agronomie, Société et Environnement, 2009
This paper reviews the current situation with regard to a total feed ban on the use of processed animal proteins in feed for meat producing animals within the EU. The scientific aspects surrounding the development of control tools are discussed.
Woodgate SL.   +3 more
doaj  

Impacts of Climate Change on Animal Production and Quality of Animal Food Products

open access: yes, 2011
Nowadays, almost all inhabitants of the Earth are affected by different health problems associated with nutrition, although their causes are in striking contrast with each other. In the developed societies certain chronic, non-infectious diseases are caused not only by overfeeding but also by an unhealthy ratio of the ingested nutrients.
Babinszky, L.   +2 more
openaire   +2 more sources

Consumers' Willingness to Pay for Additional Information on Food Quality and Safety [PDF]

open access: yes
Most quality properties of food products can be considered as credence characteristics, quality of which cannot be inferred before the purchase, and sometimes not even after the purchase.
Kola, Jukka, Latvala, Terhi
core   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Product differentiation under the WTO; An analysis of labelling and tariff or tax measures concerning farm animal welfare [PDF]

open access: yes
This report examines the possibility of giving preferential treatment to imports of meat products that meet improved standards in terms of animal welfare in production.
Achterbosch, Thom J.   +2 more
core   +1 more source

Identifying customer satisfaction at New Lives Animal Rescue Opshop [PDF]

open access: yes, 2018
New lives animal rescue is a registered charity which is rescuing and rehoming almost all kinds of animals. They collect donated goods from people and sell those items at second hand price through the Opshop.
Patel, Umang, Silva, Dhammika
core  

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy